Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting

以兹提米比 冠状动脉 医学 内皮功能障碍 心脏病学 内科学 冠状动脉支架术 支架 内皮 动脉 他汀类 再狭窄
作者
Susumu Takase,Tetsuya Matoba,Soichi Nakashiro,Yasushi Mukai,Shujiro Inoue,Keiji Oi,Taiki Higo,Shunsuke Katsuki,Masao Takemoto,Nobuhiro Suematsu,Kenichi Eshima,Kenji Miyata,Mitsutaka Yamamoto,Makoto Usui,Kenji Sadamatsu,Shinji Satoh,Toshiaki Kadokami,Kiyoshi Hironaga,Ikuyo Ichi,Koji Todaka,Junji Kishimoto,Kensuke Egashira,Kenji Sunagawa
出处
期刊:Arteriosclerosis, Thrombosis, and Vascular Biology [Lippincott Williams & Wilkins]
卷期号:37 (2): 350-358 被引量:41
标识
DOI:10.1161/atvbaha.116.308388
摘要

We sought to investigate whether treatment with ezetimibe in combination with statins improves coronary endothelial function in target vessels in coronary artery disease patients after coronary stenting.We conducted a multicenter, prospective, randomized, open-label, blinded-end point trial among 11 cardiovascular treatment centers. From 2011 to 2013, 260 coronary artery disease patients who underwent coronary stenting were randomly allocated to 2 arms (statin monotherapy, S versus ezetimibe [10 mg/d]+statin combinational therapy, E+S). We defined target vessel dysfunction as the primary composite outcome, which comprised target vessel failure during treatment and at the 6- to 8-month follow-up coronary angiography and coronary endothelial dysfunction determined via intracoronary acetylcholine testing performed in cases without target vessel failure at the follow-up coronary angiography. Coadministration of ezetimibe with statins further lowered low-density lipoprotein cholesterol levels (83±23 mg/dL in S versus 67±23 mg/dL in E+S; P<0.0001), with significant decreases in oxidized low-density lipoprotein and oxysterol levels. Among patients without target vessel failure, 46 out of 89 patients (52%) in the S arm and 34 out of 96 patients (35%) in the E+S arm were found to have coronary endothelial dysfunction (P=0.0256), and the incidence of target vessel dysfunction at follow-up was significantly decreased in the E+S arm (69/112 (62%) in S versus 47/109 (43%) in E+S; P=0.0059). A post hoc analysis of post-treatment low-density lipoprotein cholesterol-matched subgroups revealed that the incidence of both target vessel dysfunction and coronary endothelial dysfunction significantly decreased in the E+S arm, with significant reductions in oxysterol levels.The CuVIC trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction after Coronary Stenting) has shown that ezetimibe with statins, compared with statin monotherapy, improves functional prognoses, ameliorating endothelial dysfunction in stented coronary arteries, and was associated with larger decreases in oxysterol levels.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Jako完成签到 ,获得积分10
1秒前
小拉卡咪发布了新的文献求助10
1秒前
tanfor完成签到 ,获得积分10
2秒前
tom发布了新的文献求助10
2秒前
秋风的应助被chuhan采纳,获得10
2秒前
LIN发布了新的文献求助30
3秒前
molihuakai的应助被科研通管家采纳,获得10
4秒前
秋水关注了科研通微信公众号
4秒前
4秒前
桐桐的应助被科研通管家采纳,获得10
4秒前
Lucas的应助被科研通管家采纳,获得10
5秒前
完美世界的应助被科研通管家采纳,获得10
5秒前
CipherSage的应助被科研通管家采纳,获得10
5秒前
orixero的应助被科研通管家采纳,获得10
5秒前
无花果的应助被科研通管家采纳,获得10
5秒前
5秒前
5秒前
5秒前
zp的应助被科研通管家采纳,获得20
5秒前
FashionBoy的应助被科研通管家采纳,获得10
5秒前
6秒前
minting完成签到 ,获得积分10
6秒前
8秒前
8秒前
8秒前
8秒前
茉莉花发布了新的文献求助30
9秒前
carol7298发布了新的文献求助10
9秒前
fantasy的应助被小祝没吃饱采纳,获得10
11秒前
11秒前
Dyying发布了新的文献求助10
11秒前
经十路以东的应助被MMLi采纳,获得10
11秒前
12秒前
Chllerye发布了新的文献求助10
12秒前
12秒前
cdercder的应助被云隐采纳,获得10
13秒前
jxc完成签到,获得积分10
13秒前
gxy发布了新的文献求助10
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194041
求助须知:如何正确求助?哪些是违规求助? 9579979
关于积分的说明 21868799
捐赠科研通 7793641
什么是DOI,文献DOI怎么找? 3437477
关于科研通互助平台的介绍 2560942
邀请新用户注册赠送积分活动 2484251